MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-10-0004503
Surbhitam Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.54 Cr
▲ 23% YoY
Net profit · FY 2025
₹26.04 Lakh
Net margin 5.7%
EBITDA · FY 2025
₹43.66 Lakh
EBITDA margin 9.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Surbhitam Pharmaceuticals Private Limited
Data last updated:
Surbhitam Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 January 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2011PTC212531. Its GSTIN is 07AAPCS3480A1ZD (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandreshwar Singh and Rama Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A – 126H Paryavaran Complex Maidan Garhi Road, New Delhi, Delhi, India – 110030.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.54 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹26.04 Lakh (net margin 5.7%) and EBITDA of ₹43.66 Lakh (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 15% over five years.
Surbhitam Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0004503). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surbhitam.com.
Company details
CIN U85100DL2011PTC212531
Registration Number 212531
Incorporation Date 13 January 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-10-0004503
Key People
Chandreshwar Singh Director Rama Singh Director Recognitions & Rankings of Surbhitam Pharmaceuticals
Contact details
Surbhitam Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is surbhitam.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 126H Paryavaran Complex Maidan Garhi Road, New Delhi, Delhi, India – 110030
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Surbhitam Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Surbhitam Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Surbhitam Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Surbhitam Pharmaceuticals Private Limited, buy the company report.
Financials of Surbhitam Pharmaceuticals Private Limited
FY 2024 filings availableSurbhitam Pharmaceuticals Private Limited reported revenue of ₹4.54 Cr (up 23% YoY) for FY 2025.
Revenue · FY 2025
₹4.54 Cr ▲ 23%
Net profit · FY 2025
₹26.04 Lakh margin 5.7%
EBITDA · FY 2025
₹43.66 Lakh margin 9.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 14%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 88%
3 years · compounded
▲ 4%
5 years · compounded
▲ 44%
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 23% growth in the latest year. EBITDA rose 88% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹43.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.6% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Surbhitam Pharmaceuticals Private Limited, buy the company report.
Board of directors of Surbhitam Pharmaceuticals Private Limited
Surbhitam Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandreshwar Singh | Director | 13 Jan 2011 | 15 Years 9 Months | Current |
| Rama Singh | Director | 13 Jan 2011 | 15 Years 9 Months | Current |
Peer comparison
Surbhitam Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Joslin Pharmaa India Private Limited | ₹4.55 Cr (FY 2024) | 12.0% | Coimbatore, Tamil Nadu, India | |||
| Chemiquest Research India Private Limited | ₹4.55 Cr (FY 2025) | 9.0% | Mumbai, Maharashtra, India | |||
| Rubisco Pharmaceuticals Private Limited | ₹4.54 Cr (FY 2025) | 13.0% | Patna, Bihar, India | |||
| Surbhitam Pharmaceuticals Private Limitedthis company | ₹4.54 Cr (FY 2025) | ₹26.04 Lakh | 5.7% | 23.0% | New Delhi, Delhi, India | |
| Lee Health Domain India Private Limited | ₹4.53 Cr (FY 2025) | 118.0% | Hyderabad, Telangana, India | |||
| Novelix Pharmaceuticals Limited | ₹4.53 Cr (FY 2024) | 136.0% | Hyderabad, Telangana, India | |||
| Medigem Pharmaceuticals Private Limited | ₹4.52 Cr (FY 2024) | 1186.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Surbhitam Pharmaceuticals Private Limited, buy the company report.
Auditor
Surbhitam Pharmaceuticals Private Limited is audited by GS Bawa and Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GS Bawa and Company | FY 2023 | 025011N |
Shareholding
The shareholding of Surbhitam Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Surbhitam Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Surbhitam Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Surbhitam Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Surbhitam Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAPCS3480A1ZD | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Surbhitam Pharmaceuticals Private Limited, buy the company report.
Recent activity
Surbhitam Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Chandreshwar Singh was appointed as Director on 13 Jan 2011.
AGM
Surbhitam Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Surbhitam Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Appointed
Chandreshwar Singh was appointed as Director.
Appointed
Rama Singh was appointed as Director.
Incorporation
13 Jan 2011
Surbhitam Pharmaceuticals Private Limited was registered on 13 Jan 2011 with Roc Delhi & aged 15 years 9 months as per MCA records.
Frequently asked questions
Surbhitam Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 January 2011 (15+ years old) and is registered under CIN U85100DL2011PTC212531.
Surbhitam Pharmaceuticals has 2 current directors:
- Chandreshwar Singh - Director
- Rama Singh - Director
The latest financial statements of Surbhitam Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Surbhitam Pharmaceuticals is 07AAPCS3480A1ZD, registered in Delhi.
The CIN (Corporate Identification Number) of Surbhitam Pharmaceuticals is U85100DL2011PTC212531. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surbhitam Pharmaceuticals was incorporated on 13 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Surbhitam Pharmaceuticals by revenue are Joslin Pharmaa India Private Limited, Chemiquest Research India Private Limited, Rubisco Pharmaceuticals Private Limited, Lee Health Domain India Private Limited, Novelix Pharmaceuticals Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Chandreshwar Singh was appointed as Director on 13 Jan 2011. Rama Singh was appointed as Director on 13 Jan 2011.
Yes, Surbhitam Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-10-0004503).
Surbhitam Pharmaceuticals can be reached through the website surbhitam.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Surbhitam Pharmaceuticals is at A – 126H Paryavaran Complex Maidan Garhi Road, New Delhi, Delhi, India – 110030.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages